US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Sn-d

Reason Lack of Processing Controls.

Synthetopes Inc D-1403-2019
Class II · Moderate risk Terminated

Sn-Mertiatide Kit

Reason Lack of Processing Controls.

Synthetopes Inc D-1401-2019
Class II · Moderate risk Terminated

Sn-DMSA solution

Reason Lack of Processing Controls.

Synthetopes Inc D-1400-2019
Class II · Moderate risk Terminated

Pentreotide

Reason Lack of Processing Controls.

Synthetopes Inc D-1399-2019
Class I · High risk Terminated

Pecgen DMX Cough Suppressant Expectorant

Reason Labeling: Incorrect Instructions; The product has been found to provide incorrect dosage information on its label due to a typographical error. The drug facts label incorrectly states children 6 to under 2 years of age, 1 teaspoonful every 4 hours, not to exceed 4 teaspoonfuls in 24 hours or directed by physician. The label should state children 6 to under 12, 1 teaspoonful every 4 hours, not to exceed 4 teaspoonfuls in 24 hours or as directed by physician. Additionally, the label does not advise consumers to consult a doctor for children under 2 years of age.

Novis PR, Inc. NDC 52083-630-16 D-1395-2019
Class II · Moderate risk Terminated

Trimix 30mg/1 mg/10mcg/mL

Reason Lack of Sterility Assurance.

Pharm D Solutions, LLC D-1339-2019
Class II · Moderate risk Terminated

Testosterone Cypionate 200 mg/mL

Reason Lack of Sterility Assurance.

Pharm D Solutions, LLC NDC 69699-1702-10 D-1338-2019
Class II · Moderate risk Terminated

Testosterone Cyp/Pro 95/5%

Reason Lack of Sterility Assurance.

Pharm D Solutions, LLC D-1337-2019
Class II · Moderate risk Terminated

Testosterone 200 mg/mL

Reason Lack of Sterility Assurance.

Pharm D Solutions, LLC NDC 69699-1702-30 D-1336-2019
Class II · Moderate risk Terminated

Sermorelin/GHRP-2 &6

Reason Lack of Sterility Assurance.

Pharm D Solutions, LLC D-1335-2019
Class II · Moderate risk Terminated

Sermorelin/GHRP-2 &6

Reason Lack of Sterility Assurance.

Pharm D Solutions, LLC D-1334-2019
Class II · Moderate risk Terminated

Sermorelin/GHRP-2 & 6

Reason Lack of Sterility Assurance.

Pharm D Solutions, LLC D-1333-2019
Class II · Moderate risk Terminated

Lipo MIC-12

Reason Lack of Sterility Assurance.

Pharm D Solutions, LLC D-1328-2019
Class II · Moderate risk Terminated

Human Chorionic Gonadotropin 5

Reason Lack of Sterility Assurance.

Pharm D Solutions, LLC D-1325-2019
Class II · Moderate risk Terminated

B-complex

Reason Lack of Sterility Assurance.

Pharm D Solutions, LLC NDC 69699-1611-30 D-1323-2019
Class II · Moderate risk Terminated

Cefdinir for Oral Suspension USP

Reason Complaint received of metal piece identified in the product bottle prior to the reconstitution.

Lupin Pharmaceuticals Inc. NDC 68180-723-20 D-1320-2019